Rocket Pharmaceuticals

Rocket Pharmaceuticals
A biotechnology company developing genetic therapies for rare disorders.
About
What does Rocket Pharmaceuticals do?
Rocket Pharmaceuticals, Inc. is a fully integrated, commercial-stage biotechnology company focused on advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need. The company has recently strengthened its financial position through the sale of a Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million.
What is Rocket Pharmaceuticals's revenue?
StartupHub estimates Rocket Pharmaceuticals's annual revenue at $14.2M (range $7.8M to $36.9M, 68% confidence), based on comparable companies in the sector.
What is Rocket Pharmaceuticals's valuation?
StartupHub estimates Rocket Pharmaceuticals's effective valuation at $557.9M (range $390.5M to $725.3M, 28% confidence), based on comparable companies in the sector.
How much funding has Rocket Pharmaceuticals raised?
Rocket Pharmaceuticals has raised a total of $383M in funding. The most recent round on record is Acquisition.
Where is Rocket Pharmaceuticals headquartered?
Rocket Pharmaceuticals is headquartered in Cranbury, New Jersey, USA.
When was Rocket Pharmaceuticals founded?
Rocket Pharmaceuticals was founded in 2015.
What industry does Rocket Pharmaceuticals operate in?
Rocket Pharmaceuticals operates in Biotechnology, Pharmaceuticals, Healthcare, Genetics, Gene Therapy, Rare Diseases.
How many employees does Rocket Pharmaceuticals have?
Rocket Pharmaceuticals has approximately 100 people on record.
No comments yet. Be the first to share your take.
